Regulations and Reform

Anti-Rescheduling Groups Attempting to Stay Schedule III Order Call Government’s Response ‘Meritless’

A drug testing group and pharmaceutical company asked a federal court to stay the order, claiming the DOJ has no defense other than diversions.

17 Senate Democrats File Bill to Federally Legalize Cannabis

The Cannabis Administration and Opportunity Act would deschedule cannabis, removing it from the Controlled Substances Act.

Massachusetts Cannabis Repeal Petition Qualifies for 2026 Ballot; Objector Files New Challenge

The state’s Elections Division certified the final batch of signatures, but the objector is claiming that several signatures should be disqualified.

Virginia Lawmakers Respond to ‘Inaccurate Reports’ on Cannabis Sales Bill

The lawmakers who drew up the state’s adult-use sales legislation that was incorporated into the state budget refuted claims about distribution and underage possession.

Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I

Wyoming Attorney General Keith G. Kautz announced that he won’t loosen restrictions on cannabis after there was little public interest in doing so.

Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says

The Department of Justice argued that anti-rescheduling groups attempting to stay a Schedule III order have ‘pocketbook interests’ in prohibition.

American Bankers Association Presses Congress to Pass SAFE Banking Act

The financial trade group for the U.S. banking industry wrote a letter to congressional leaders, urging them to co-sponsor the cannabis legislation.

Prohibitionists Punch Back at Cannabis Rescheduling Hearing

Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.

DEA Comes Out Swinging in Cannabis Rescheduling Hearing

The government argued in support of currently accepted medical use; anti-rescheduling parties attempted to poke holes in the Schedule III recommendation.

DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing

The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.

8 Bipartisan US House Lawmakers Reintroduce SAFE Banking Act

The legislation would prohibit federal regulators from penalizing financial institutions simply because they choose to service the cannabis industry.

4 Bipartisan Senators File SAFE Banking Act for Cannabis Industry

The legislation, which previously passed seven times in the House, aims to provide a safe harbor to banks and credit unions wishing to serve the industry.

Page 1 of 12

Next Page